Skip to main content
TASLY PHARMACEUTICAL GROUP CO.,LTD. logo

TASLY PHARMACEUTICAL GROUP CO.,LTD. — Investor Relations & Filings

Ticker · 600535 ISIN · CNE000001C81 LEI · 300300JB9F71F58FIC88 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,889 across all filing types
Latest filing 2025-12-09 Governance Information
Country CN China
Listing Shanghai Stock Exchange 600535

About TASLY PHARMACEUTICAL GROUP CO.,LTD.

http://www.tasly.com

Tasly Pharmaceutical Group Co., Ltd. specializes in the research, development, and production of modern Traditional Chinese Medicine (TCM), biological products, and chemical pharmaceuticals. The company is primarily known for its flagship cardiovascular treatment, Compound Danshen Dripping Pills, which represents a significant advancement in the modernization and standardization of herbal medicine. Its therapeutic portfolio covers cardiovascular, cerebrovascular, digestive, and metabolic diseases, as well as oncology. Tasly utilizes high-tech manufacturing processes and maintains a strong focus on R&D to bridge traditional therapies with modern clinical standards. The organization also explores digital health solutions and innovative drug delivery systems to enhance its comprehensive healthcare offerings.

Recent filings

Filing Released Lang Actions
天士力公司章程（2025年12月修订）
Governance Information Classification · 100% confidence The document is titled "公司章程" which translates to "Articles of Association" or "Company Bylaws". It contains detailed chapters on company governance, shareholder rights, board structure, management, financial accounting, profit distribution, audit, and other corporate governance matters. It is a comprehensive internal governance document rather than a financial report or announcement. There is no indication of financial statements, earnings data, or regulatory filings related to financial results. The document is lengthy (15,000 characters) and is a formal governance charter of the company. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-12-09 Chinese
天士力董事会战略与ESG委员会工作细则（2025年12月修订）
Governance Information Classification · 95% confidence The document is a detailed set of rules and procedures for the Board's Strategic and ESG Committee of a company. It outlines the committee's composition, responsibilities, decision-making processes, and governance related to ESG and strategic matters. There are no financial statements, no earnings data, no voting results, no announcements of reports, no legal proceedings, no capital changes, or other typical financial or regulatory filing content. The document focuses on governance structure and internal rules related to ESG and strategy oversight by the board committee. This matches the description of Governance Information (CGR), which covers internal rules, board structure, and governance practices. The document length is 3649 characters, which is sufficient for a detailed governance document but not a full financial report. Therefore, the appropriate classification is CGR with high confidence.
2025-12-09 Chinese
天士力董事会议事规则（2025年12月修订）
Governance Information Classification · 100% confidence The document is titled '董事会议事规则' which translates to 'Board Meeting Rules' or 'Rules of Procedure for the Board of Directors'. It details the internal rules, procedures, and governance practices for the company's board meetings, including meeting convocations, voting procedures, responsibilities, and record-keeping. There is no financial data, audit information, or report publication mentioned. The content focuses on governance structure and board operations, aligning with governance information rather than financial or regulatory filings. Therefore, the document fits the category of Governance Information (CGR).
2025-12-09 Chinese
天士力关于变更会计师事务所的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the change of the company's accounting firm from Tianjian CPA to KPMG Huazhen CPA for the 2025 fiscal year. It details the background, qualifications, and audit fees of the new auditor, as well as the approval process by the audit committee and board. There are no actual financial statements or audit reports included, only information about the auditor change and related procedural approvals. The document length is 3572 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document is best classified as an Audit Report / Information (AR) type, since it relates specifically to audit firm change and audit-related information, but is not a full annual report or audit report itself. However, given the document is an announcement of auditor change and not the audit report itself, it fits the Audit Report / Information category rather than Annual Report or Regulatory Filing. FY 2025
2025-12-09 Chinese
天士力内部问责管理制度（2025年12月修订）
Governance Information Classification · 95% confidence The document is titled '内部问责管理制度' which translates to 'Internal Accountability Management System' and outlines the company's internal governance and accountability procedures related to securities law violations and management responsibilities. It details principles, procedures, and measures for internal accountability within the company, including the roles of the board and committees. There is no financial data, earnings information, or regulatory filing of financial results. It is a governance-related document focusing on internal rules and management practices rather than a report or announcement of financial or operational results. Therefore, it fits best under Governance Information (CGR). The document length is 3440 characters, which is relatively short but contains substantive governance content, not just an announcement or notice.
2025-12-09 Chinese
天士力董事和高级管理人员持有及买卖本公司股份的专项管理制度
Governance Information Classification · 95% confidence The document is a detailed internal policy titled '董事和高级管理人员持有及买卖本公司股份的专项管理制度' which translates to 'Special Management System for Directors and Senior Management Personnel Holding and Trading Company Shares.' It outlines rules and procedures for directors and senior management regarding their shareholdings and transactions, including compliance with laws, reporting obligations, restrictions on trading periods, and penalties for violations. This is a governance-related document focusing on internal rules about shareholding and trading by company insiders. It is not an announcement, financial report, or regulatory filing per se, but a governance policy document. Therefore, the most appropriate classification is Governance Information (CGR). The document length is 4272 characters, which is substantial and contains detailed governance rules rather than a brief announcement or certification.
2025-12-09 Chinese

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.